Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Phase 3 Cancer Trials

Hawaii

Phase 3 cancer trials in Hawaii

28 Phase 3 cancer studies are recruiting participants at sites in 5 cities across Hawaii as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 306-7888
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Hawaii city with a recruiting study

By research area: Breast Cancer (9), Lung Cancer (9), Lymphoma (5), Prostate Cancer (3), Pancreatic Cancer (2).

Honolulu (28), ‘Aiea (13), ‘Ewa Beach (9), Lihue (7), Kahului (4).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in Hawaii

Basic details from each study's public record (the 12 most recently updated of 28). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

    • Phase 3
    • Ages 18 to 60
    • Female participants
    Sponsor
    NRG Oncology
    Recruiting in
    ‘Aiea · ‘Ewa Beach · Honolulu · and 2 more U.S. locations
    Registry record
    NCT05879926 · updated
  2. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Honolulu
    Registry record
    NCT06748222 · updated
  3. A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Honolulu
    Registry record
    NCT07174336 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Hawaii on ClinicalTrials.gov.

Lung cancer: recently updated in Hawaii

  1. Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    ‘Aiea · ‘Ewa Beach · Honolulu
    Registry record
    NCT06498635 · updated
  2. Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Daiichi Sankyo
    Recruiting in
    Honolulu
    Registry record
    NCT06899126 · updated
  3. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    ‘Aiea · Honolulu
    Registry record
    NCT04267848 · updated
  4. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Honolulu
    Registry record
    NCT04181060 · updated
  5. Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy

    • Phase 3
    • Ages 18 to 90
    • All sexes
    Sponsor
    ImmunityBio, Inc.
    Recruiting in
    Honolulu
    Registry record
    NCT06745908 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Hawaii on ClinicalTrials.gov.

Prostate cancer: recently updated in Hawaii

  1. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    Alliance for Clinical Trials in Oncology
    Recruiting in
    Honolulu
    Registry record
    NCT06931340 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Hawaii on ClinicalTrials.gov.

Lymphoma: recently updated in Hawaii

  1. A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

    • Phase 3
    • Ages 5 to 60
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Honolulu
    Registry record
    NCT05675410 · updated
  2. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

    • Phase 3
    • Ages 18 to 39
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Recruiting in
    ‘Aiea · Honolulu
    Registry record
    NCT03150693 · updated
  3. Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

    • Phase 3
    • Ages 65 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Recruiting in
    Honolulu
    Registry record
    NCT07321652 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Hawaii on ClinicalTrials.gov.

Ask about studies in Hawaii

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 3, including combined Phase 2/3, as each study is coded in the registry.

Phase 3 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 306-7888

or send a short form

How should we reach you?

Call